Home
About
Overview
Sharing Data
ORCID
Help
History (24)
Challenges and Approaches to Measuring Repeat Fecal Immunochemical Test for Colorectal Cancer Screening.
Presence/absence polymorphism for alternative pathogenicity islands in Pseudomonas viridiflava, a pathogen of Arabidopsis.
[Ethics for being a radiological technologist and/or a researcher].
Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: a Gynecologic Oncology Group study.
A Systematic Review of Repeat Fecal Occult Blood Tests for Colorectal Cancer Screening.
See All 24 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A Systematic Review of Repeat Fecal Occult Blood Tests for Colorectal Cancer Screening.
A Systematic Review of Repeat Fecal Occult Blood Tests for Colorectal Cancer Screening. Cancer Epidemiol Biomarkers Prev. 2020 02; 29(2):278-287.
View in:
PubMed
subject areas
Colorectal Neoplasms
Early Detection of Cancer
Humans
Mass Screening
Occult Blood
Patient Compliance
Postal Service
Reminder Systems
authors with profiles
Caitlin Murphy